e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Should we exercise caution with benzodiazepine use in patients with COPD?
Rodriguez-Roisin Robert, Garcia-Aymerich Judith
Source:
Eur Respir J 2014; 44: 284-286
Journal Issue:
August
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Rodriguez-Roisin Robert, Garcia-Aymerich Judith. Should we exercise caution with benzodiazepine use in patients with COPD?. Eur Respir J 2014; 44: 284-286
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
The effect of additional use of short-acting beta2 agonist on exercise tolerance in patients with COPD on regular long-acting bronchodilators treatments
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Which patients with COPD can potentially benefit from prophylactic use of antibiotics?
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
The rationality of the use of NIV in elderly patients with acute COPD exacerbation
Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure
Year: 2018
What is the best frequency of exercise training in patients with moderate-to-severe COPD ?
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018
How often do asthma patients claim prescribed therapy?
Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS
Year: 2017
Lung function, symptoms and prescription of inhaled steroids and long acting β2 agonists in patients managed by an integrated COPD team
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Survey of dyspnoea in COPD patients on medication and preemptive use of a short-acting β-2 agonist
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Is the coprescription of Beta-blockers and Beta2-agonists justified in patients with coexisting COPD and CHF?
Source: Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD
Year: 2009
De-implementing inappropriate inhaled steroids use in Dutch COPD patients in primary care
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
The efficacy of incentive spirometry in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 256s
Year: 2002
A systematic review and meta-analysis of the effect of dual versus mono- long-acting bronchodilator therapy on exercise endurance in COPD
Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases
Year: 2016
COPD: Are beliefs about inhaled medication associated with patients’ inhaler technique?
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
Are COPD patients taking triple combination inhalers being overmedicated during acute exacerbations?
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
Clinical and inhaled drug profile of COPD patients with indication for beta-blockers who are on beta-blockers
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Deprescribing of inhaled corticosteroids in patients with COPD with mild or moderate airflow limitation: what do patients think?
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002
Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020
Is there a problem with inhaled corticosteroid use in COPD?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020
Can we stratify our approach on physical activity and exercise in patients with COPD?
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017
Acute and chronic effects of inhaled bronchodilators in patients with 'irreversible' COPD at rest and during exercise
Source: Eur Respir J 2002; 20: Suppl. 38, 302s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept